Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
36.70
+3.47 (10.44%)
At close: Apr 24, 2025, 4:00 PM
36.17
-0.53 (-1.44%)
Pre-market: Apr 25, 2025, 5:01 AM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $27.07 billion as of April 25, 2025. Its market cap has increased by 876.76% in one year.
Market Cap
27.07B
Enterprise Value
26.67B
1-Year Change
876.76%
Ranking
Category
Stock Price
$36.70
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $27.07B, an increase of 22,650.29%. That is a compound annual growth rate of 70.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 24.51B | 86.27% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 751.40B |
| UnitedHealth Group | 396.88B |
| Johnson & Johnson | 376.30B |
| AbbVie | 312.76B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 225.44B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |